Catalyst Wire Dossier Catalyst Wire Dossier

Irinotecan hydrochloride liposome injection (II)

irinotecan liposome injection
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Irinotecan hydrochloride liposome injection (II), covering 2025-12-09 to 2026-01-06. Get the full timeline:

Most recent: Clinical Trial Update: Treatment of Irinotecan Hydrochloride Liposome Injection II in China: a Real World Study of Pancreatic Cancer Patients

See pricing